Fund Evaluation Group, LLC
- SEC CIK
- 0001356249
- Latest filing
- Aug 7, 2026
FBLG holding history
FibroBiologics, Inc. in every 13F filed by Fund Evaluation Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FBLG overviewAll 13F holders of FBLGFull Q2 2026 holdings
- Shares (Q2 2026)
- 51,794
- Value
- $49.1K
- % of portfolio
- <0.1%
- Quarters held
- 2
- Since Q1 2026